CD4-M-33

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCD4-M-33
Drug Alias NameCD4-M-33
ClassificationOther
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFrench Alternative Energies And Atomic Energy Commission - Grenoble
China Registration ClassN/A

Develop Information

Active CompaniesFrench Alternative Energies And Atomic Energy Commission - Grenoble
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A